"The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for"...
Because of the possibility of mutagenic effects, patients should be advised to use contraceptive measures.
Last reviewed on RxList: 8/6/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Emcyt Information
Emcyt - User Reviews
Emcyt User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.